Sunao Manabe is the global CEO of Daiichi Sankyo, which is headquartered in Japan. He spoke with BioPharmaDispatch during a recent trip to Australia.
Daiichi Sankyo CEO on the company's logical expansion into Australia
November 21, 2023 Latest NewsBioPharmaBioPharmaDispatch ExecutiveNews of the Day
Latest Video
New Stories
-
The Dispatched 'Week in Review' Podcast - 28 March
March 28, 2025 - - Podcast -
Work of the HTA Review implementation group will continue during caretaker
March 28, 2025 - - Latest News -
Health department quietly launches major review of blood products supply
March 27, 2025 - - Latest News -
Mesoblast says its FDA-approved mesenchymal stromal cell therapy available for sale in the US
March 27, 2025 - - Australian Biotech -
Neuren initiates development of NNZ-2591 to treat HIE in newborns
March 27, 2025 - - Australian Biotech -
Amplia Therapeutics reports updated data from pancreatic cancer trial
March 27, 2025 - - Australian Biotech -
Debate has provided an invaluable platform to focus attention on PBS problems
March 27, 2025 - - Latest News